These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29641433)

  • 1. The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis.
    Bello RO; Chin VK; Abd Rachman Isnadi MF; Abd Majid R; Atmadini Abdullah M; Lee TY; Amiruddin Zakaria Z; Hussain MK; Basir R
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-33: a potential therapeutic target in autoimmune diseases.
    Wang S; Ding L; Liu SS; Wang C; Leng RX; Chen GM; Fan YG; Pan HF; Ye DQ
    J Investig Med; 2012 Dec; 60(8):1151-6. PubMed ID: 23076162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis.
    Furue K; Yamamura K; Tsuji G; Mitoma C; Uchi H; Nakahara T; Kido-Nakahara M; Kadono T; Furue M
    Acta Derm Venereol; 2018 Jan; 98(1):5-13. PubMed ID: 28967976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.
    Guan SY; Leng RX; Khan MI; Qureshi H; Li XP; Ye DQ; Pan HF
    Inflammation; 2017 Feb; 40(1):303-310. PubMed ID: 27696334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology of IL-38 and its role in disease.
    van de Veerdonk FL; de Graaf DM; Joosten LA; Dinarello CA
    Immunol Rev; 2018 Jan; 281(1):191-196. PubMed ID: 29247986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-18: a regulator of cancer and autoimmune diseases.
    Esmailbeig M; Ghaderi A
    Eur Cytokine Netw; 2017 Nov; 28(4):127-140. PubMed ID: 29478963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and pathological activities of interleukin-22.
    Perusina Lanfranca M; Lin Y; Fang J; Zou W; Frankel T
    J Mol Med (Berl); 2016 May; 94(5):523-34. PubMed ID: 26923718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-19 as an Immunoregulatory Cytokine.
    Fujimoto Y; Kuramoto N; Yoneyama M; Azuma YT
    Curr Mol Pharmacol; 2021; 14(2):191-199. PubMed ID: 32329704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 32, inflammation and cancer.
    Hong JT; Son DJ; Lee CK; Yoon DY; Lee DH; Park MH
    Pharmacol Ther; 2017 Jun; 174():127-137. PubMed ID: 28223235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells.
    Schmieder A; Multhoff G; Radons J
    Cytokine; 2012 Nov; 60(2):514-21. PubMed ID: 22819319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological functions and clinical implications of interleukin-34 in inflammatory diseases.
    Ge Y; Huang M; Zhu XM; Yao YM
    Adv Protein Chem Struct Biol; 2020; 119():39-63. PubMed ID: 31997772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Important role of interleukin-35 in infectious diseases and its significance].
    Yao R; Wu Y; Ma B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):848-852. PubMed ID: 28936965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging cytokine targets in rheumatoid arthritis.
    Asquith DL; McInnes IB
    Curr Opin Rheumatol; 2007 May; 19(3):246-51. PubMed ID: 17414950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of interleukin-22 in inflammatory bowel disease.
    Li LJ; Gong C; Zhao MH; Feng BS
    World J Gastroenterol; 2014 Dec; 20(48):18177-88. PubMed ID: 25561785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-36 cytokines in inflammatory and malignant diseases: not the new kid on the block anymore.
    Byrne J; Baker K; Houston A; Brint E
    Cell Mol Life Sci; 2021 Sep; 78(17-18):6215-6227. PubMed ID: 34365521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of IL-36 cytokines and their role in disease.
    Gresnigt MS; van de Veerdonk FL
    Semin Immunol; 2013 Dec; 25(6):458-65. PubMed ID: 24355486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.
    Paunovic V; Carroll HP; Vandenbroeck K; Gadina M
    Rheumatology (Oxford); 2008 Jun; 47(6):771-6. PubMed ID: 18238793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases.
    Hurme M; Lahdenpohja N; Santtila S
    Ann Med; 1998 Oct; 30(5):469-73. PubMed ID: 9814833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines.
    Chen Z; Colon I; Ortiz N; Callister M; Dong G; Pegram MY; Arosarena O; Strome S; Nicholson JC; Van Waes C
    Cancer Res; 1998 Aug; 58(16):3668-76. PubMed ID: 9721877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
    Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
    Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.